Lv5
886 积分 2021-07-06 加入
New drug therapies for hypertension
2天前
求助中
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
3天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
11天前
已完结
Discovery of PVD-06 as a Subtype-Selective and Efficient PTPN2 Degrader
1个月前
已完结
RSK inhibitors as potential anticancer agents: Discovery, optimization, and challenges
1个月前
已完结
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer
1个月前
已完结
Heart Failure with Preserved Ejection Fraction
1个月前
已完结
Translating New Obesity Definitions Into Clinical Practice
2个月前
已关闭
Bumetanide Nasal Spray: First Approval
2个月前
已关闭
Myeloperoxidase inhibition in the landscape of anti-inflammatory therapies for heart failure with preserved ejection fraction: the ENDEAVOR trial
2个月前
已完结
皖公网安备34019202002308
